Clinical Trial Update: IV Iron-induced Hypophosphatemia After RYGB [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on IV iron-induced hypophosphatemia after Roux-en-Y gastric bypass, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatemia

Drugs mentioned

• IV iron

Snippet

Sponsor: Lucie Favre | Conditions: Hypophosphatemia, Roux-en-Y Gastric Bypass | Phase 4 | Status: RECRUITING